583 related articles for article (PubMed ID: 10903728)
1. The alloreactive and self-restricted CD4+ T cell response directed against a single MHC class II/peptide combination.
Kovalik JP; Singh N; Mendiratta SK; Martin WD; Ignatowicz L; Van Kaer L
J Immunol; 2000 Aug; 165(3):1285-93. PubMed ID: 10903728
[TBL] [Abstract][Full Text] [Related]
2. Peptide dependency of alloreactive CD4+ T cell responses.
Mendiratta SK; Kovalik JP; Hong S; Singh N; Martin WD; Van Kaer L
Int Immunol; 1999 Mar; 11(3):351-60. PubMed ID: 10221647
[TBL] [Abstract][Full Text] [Related]
3. Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers.
Whitelegg AM; Oosten LE; Jordan S; Kester M; van Halteren AG; Madrigal JA; Goulmy E; Barber LD
J Immunol; 2005 Aug; 175(3):1706-14. PubMed ID: 16034111
[TBL] [Abstract][Full Text] [Related]
4. Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I alpha-helical residues.
Hornell TM; Solheim JC; Myers NB; Gillanders WE; Balendiran GK; Hansen TH; Connolly JM
J Immunol; 1999 Sep; 163(6):3217-25. PubMed ID: 10477590
[TBL] [Abstract][Full Text] [Related]
5. Alpha beta TCRs differ in the degree of their specificity for the positively selecting MHC/peptide ligand.
Kraj P; Pacholczyk R; Ignatowicz L
J Immunol; 2001 Feb; 166(4):2251-9. PubMed ID: 11160279
[TBL] [Abstract][Full Text] [Related]
6. The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues.
Arnold PY; La Gruta NL; Miller T; Vignali KM; Adams PS; Woodland DL; Vignali DA
J Immunol; 2002 Jul; 169(2):739-49. PubMed ID: 12097376
[TBL] [Abstract][Full Text] [Related]
7. Induction of T-cell response to cryptic MHC determinants during allograft rejection.
Boisgérault F; Anosova NG; Tam RC; Illigens BM; Fedoseyeva EV; Benichou G
Hum Immunol; 2000 Dec; 61(12):1352-62. PubMed ID: 11163093
[TBL] [Abstract][Full Text] [Related]
8. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis.
Murphy B; Magee CC; Alexander SI; Waaga AM; Snoeck HW; Vella JP; Carpenter CB; Sayegh MH
J Clin Invest; 1999 Mar; 103(6):859-67. PubMed ID: 10079107
[TBL] [Abstract][Full Text] [Related]
10. Unexpected reactivities of T cells selected by a single MHC-peptide ligand.
Singh N; Van Kaer L
J Immunol; 1999 Oct; 163(7):3583-91. PubMed ID: 10490950
[TBL] [Abstract][Full Text] [Related]
11. Detection of low-avidity CD4+ T cells using recombinant artificial APC: following the antiovalbumin immune response.
Mallet-Designe VI; Stratmann T; Homann D; Carbone F; Oldstone MB; Teyton L
J Immunol; 2003 Jan; 170(1):123-31. PubMed ID: 12496391
[TBL] [Abstract][Full Text] [Related]
12. Amino acid substitutions in the putative MHC class II "dimer of dimers" interface inhibit CD4+ T cell activation.
Lindstedt R; Monk N; Lombardi G; Lechler R
J Immunol; 2001 Jan; 166(2):800-8. PubMed ID: 11145653
[TBL] [Abstract][Full Text] [Related]
13. Peptide specificity of alloreactive CD4 positive T lymphocytes directed against a major histocompatibility complex class I disparity.
Ossevoort MA; De Bruijn ML; Van Veen KJ; Kast WM; Melief CJ
Transplantation; 1996 Nov; 62(10):1485-91. PubMed ID: 8958276
[TBL] [Abstract][Full Text] [Related]
14. Flexibility in MHC and TCR recognition: degenerate specificity at the T cell level in the recognition of promiscuous Th epitopes exhibiting no primary sequence homology.
Joshi SK; Suresh PR; Chauhan VS
J Immunol; 2001 Jun; 166(11):6693-703. PubMed ID: 11359825
[TBL] [Abstract][Full Text] [Related]
15. Processing and reactivity of T cell epitopes containing two cysteine residues from hen egg-white lysozyme (HEL74-90).
Kang HK; Mikszta JA; Deng H; Sercarz EE; Jensen PE; Kim BS
J Immunol; 2000 Feb; 164(4):1775-82. PubMed ID: 10657624
[TBL] [Abstract][Full Text] [Related]
16. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.
Wang W; Man S; Gulden PH; Hunt DF; Engelhard VH
J Immunol; 1998 Feb; 160(3):1091-7. PubMed ID: 9570521
[TBL] [Abstract][Full Text] [Related]
17. Recombinant adenovirus coexpressing covalent peptide/MHC class II complex and B7-1: in vitro and in vivo activation of myelin basic protein-specific T cells.
Chen J; Huber BT; Grand RJ; Li W
J Immunol; 2001 Aug; 167(3):1297-305. PubMed ID: 11466346
[TBL] [Abstract][Full Text] [Related]
18. T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice.
Suh CH; Freed JH; Cohen PL
J Immunol; 2003 Feb; 170(4):2229-35. PubMed ID: 12574397
[TBL] [Abstract][Full Text] [Related]
19. On the self-referential nature of naive MHC class II-restricted T cells.
Viret C; He X; Janeway CA
J Immunol; 2000 Dec; 165(11):6183-92. PubMed ID: 11086052
[TBL] [Abstract][Full Text] [Related]
20. The orientation and nature of the interaction between beef insulin-specific TCRs and the insulin/class II MHC complex.
Wither JE; Vukusic B
J Immunol; 1999 Feb; 162(4):2113-22. PubMed ID: 9973485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
